A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
Coxsackievirus A16 (CA16) has caused worldwide epidemics of hand, foot and mouth disease (HFMD), particularly in infants and pre-school children. Currently, there are no vaccines or antiviral drugs available for CA16-associated disease. In this study, a CA16-specific monoclonal antibody (MAb) NA11F1...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , |
---|---|
Format: | Livre |
Publié: |
Taylor & Francis Group,
2019-10-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Cote: |
A1234.567 |
---|---|
Exemplaire 1 | Disponible |